MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics | AVESİS

Bursa Uludag University Research Information System

MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics

Aksoy S., Kanat O., Tunca B. , Ertas H., Ugras N., Ozturk E., ...More

International Congress on Targeted Anticancer Therapies (TAT), Paris, France, 5 - 07 March 2018, vol.29

Publication Type: Conference Paper / Summary Text
Volume: 29
City: Paris
Country: France